TTK Healthcare

Who are in the management team of TTK Healthcare?

As of March 2023, TTK Healthcare's management team includes T T Raghunathan (Executive Chairman), S Kalyanaraman (Whole Time Director), and several non-executive directors, ensuring a diverse governance structure.

As of March 2023, the management team of TTK Healthcare includes:<BR><BR>1. T T Raghunathan - Executive Chairman<BR>2. R K Tulshan - Non-Executive & Non-Independent Director<BR>3. K Shankaran - Non-Executive & Non-Independent Director<BR>4. S Kalyanaraman - Whole Time Director & Secretary<BR>5. Vandana R Walvekar - Non-Executive & Independent Director<BR>6. Girish Rao - Non-Executive & Independent Director<BR>7. S Balasubramanian - Non-Executive & Independent Director<BR>8. N Ramesh Rajan - Non-Executive & Independent Director<BR>9. V Ranganathan - Non-Executive & Independent Director<BR>10. T T Mukund - Director<BR><BR>This team comprises a mix of executive and non-executive members, with various designations contributing to the governance of the company.

When is the next results date for TTK Healthcare?

No Upcoming Board Meetings

What does TTK Healthcare do?

TTK Healthcare Ltd. operates in pharmaceuticals, consumer products, medical devices, and foods. As of March 2025, it reported net sales of ₹190 Cr and a net profit of ₹16 Cr, with a market cap of ₹1,735 Cr.

Overview:<BR>TTK Healthcare Ltd. operates in the diversified industry, focusing on pharmaceuticals, consumer products, medical devices, foods, and protective devices.<BR><BR>History:<BR>Incorporated in May 1958 as Orient Pharma, the company was renamed TTK Pharma in November 1981. The latest quarterly results reported net sales and profit for March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 190 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 16 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 1,735 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 25.00 <BR>Industry P/E: 35 <BR>Dividend Yield: 0.81% <BR>Debt-Equity: -0.72 <BR>Return on Equity: 6.64% <BR>Price to Book: 1.64 <BR><BR>Contact Details:<BR>Address: 6 Cathedral Road, Chennai Tamil Nadu: 600086 <BR>Tel: 91-44-28116106-28116110 <BR>Email: info@ttkhealthcare.com <BR>Website: http://www.ttkhealthcare.com

Has TTK Healthcare declared dividend?

TTK Healthcare Ltd. has declared a 100% dividend, amounting to ₹10 per share, with an ex-date of July 16, 2024. While the recent total returns show declines in the short term, the company has experienced significant growth over the longer term.

TTK Healthcare Ltd. has declared a 100% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 100%<BR>- Amount per share: 10<BR>- Ex-date: 16 Jul 24<BR><BR>Dividend Yield: 0.81%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -21.3%, the dividend return was 0%, resulting in a total return of -21.3%.<BR><BR>Over the past year, the price return was -14.86%, the dividend return was 0.66%, leading to a total return of -14.2%.<BR><BR>In the 2-year period, the price return was -3.25%, the dividend return was 1.58%, culminating in a total return of -1.67%.<BR><BR>For the 3-year period, the price return was 66.56%, the dividend return was 4.22%, resulting in a total return of 70.78%.<BR><BR>In the last 4 years, the price return was 81.28%, the dividend return was 5.44%, which brought the total return to 86.72%.<BR><BR>Over the past 5 years, the price return was 187.39%, the dividend return was 8.95%, leading to a total return of 196.34%.<BR><BR>Overall, TTK Healthcare has declared a substantial dividend, but the recent total returns indicate a mixed performance, with significant growth over the longer term despite recent declines in shorter periods.

Who are the peers of the TTK Healthcare?

TTK Healthcare's peers include Adani Enterprises, Godrej Industries, and 3M India, among others. TTK Healthcare has average management risk, below average growth, and a 1-year return of -17.61%, outperforming only Adani Enterprises.

Peers: The peers of TTK Healthcare are Adani Enterp., Godrej Industrie, 3M India, DCM Shriram, Swan Energy, Dhunseri Vent., Empire Inds., Krypton Industri, KCK Industries, and Aspinwall & Co.<BR><BR>Quality Snapshot: Excellent management risk is observed at 3M India, while Below Average management risk is found at Adani Enterp., Godrej Industrie, and Krypton Industri, and the rest. Average management risk is present at DCM Shriram, Swan Energy, TTK Healthcare, Dhunseri Vent., Empire Inds., and Aspinwall & Co. Growth is Excellent at Adani Enterp., Good at Godrej Industrie and KCK Industries, while Average growth is seen at DCM Shriram, Dhunseri Vent., and Aspinwall & Co., and the rest. Below Average growth is noted at 3M India, Swan Energy, TTK Healthcare, Empire Inds., and Krypton Industri. Capital Structure is Excellent at 3M India and TTK Healthcare, Good at Dhunseri Vent., and Average at DCM Shriram, Aspinwall & Co., while Below Average is found at Adani Enterp., Godrej Industrie, Swan Energy, Empire Inds., Krypton Industri, and KCK Industries.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Godrej Industrie at 53.06%, while the peer with the lowest is Adani Enterp. at -31.83%. TTK Healthcare's 1-year return is -17.61%, which is better than Adani Enterp. but worse than all other peers. Additionally, peers with negative six-month returns include Swan Energy, Krypton Industri, and TTK Healthcare.

Who are the top shareholders of the TTK Healthcare?

The top shareholders of TTK Healthcare are primarily its promoters, with T T Krishnamachari & Co. holding 67.46%. Other notable shareholders include Jupiter India Fund at 1.52% and individual investors with a combined 16.01%.

The top shareholders of TTK Healthcare are primarily its promoters, with T T Krishnamachari & Co. holding the largest share at 67.46%, represented by its partners Mr. T T Jagannathan and Mr. T T Raghunathan. Other notable shareholders include Jupiter India Fund, which holds 1.52%, and individual investors collectively owning 16.01%. Additionally, there are four mutual fund schemes that hold a combined 0.04%, and nine foreign institutional investors (FIIs) with a total holding of 1.89%.

How big is TTK Healthcare?

As of 24th July, TTK Healthcare Ltd. has a market capitalization of 1,920.00 Cr, with recent Net Sales of 801.49 Cr and a Net Profit of 81.66 Cr. The company has Shareholder's Funds of 1,065.05 Cr and Total Assets of 1,275.24 Cr.

As of 24th July, TTK Healthcare Ltd. has a market capitalization of 1,920.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, TTK Healthcare reported Net Sales of 801.49 Cr and a Net Profit of 81.66 Cr.<BR><BR>For the reporting period of March 2025, the company has Shareholder's Funds amounting to 1,065.05 Cr and Total Assets of 1,275.24 Cr.

Is TTK Healthcare overvalued or undervalued?

As of July 28, 2025, TTK Healthcare is considered undervalued with an attractive valuation grade, a PE ratio of 25.50, and competitive financial metrics, making it a potential buying opportunity despite recent underperformance compared to the Sensex.

As of 28 July 2025, TTK Healthcare's valuation grade has moved from fair to attractive, indicating a positive shift in its market perception. The company is currently considered undervalued, with a PE ratio of 25.50, an EV to EBITDA of 29.89, and a Price to Book Value of 1.69. In comparison to its peers, TTK Healthcare's PE ratio is lower than Sun Pharma's 35.57 and Divi's Lab's 79.83, both of which are categorized as expensive, while it is more favorable than Cipla's attractive PE of 23.53.<BR><BR>TTK Healthcare's financial metrics suggest it is positioned well within its industry, especially with a PEG ratio of 2.04, which is competitive against peers like Dr. Reddy's Labs at 9.35. Despite recent stock performance trailing the Sensex, particularly with a year-to-date return of -9.92% compared to the Sensex's 3.52%, the overall valuation indicates that TTK Healthcare presents a buying opportunity for investors looking for growth in the diversified healthcare sector.

How has been the historical performance of TTK Healthcare?

TTK Healthcare has shown steady growth in net sales and profit from Mar'21 to Mar'25, with net sales increasing from 636.53 Cr to 801.49 Cr and profit before tax rising from 24.84 Cr to 108.33 Cr. However, the company has faced challenges with rising costs and negative cash flow from operating activities.

Answer:<BR>The historical performance of TTK Healthcare shows a steady growth in net sales and profit over the years, with significant fluctuations in certain metrics.<BR><BR>Breakdown:<BR>TTK Healthcare's net sales have increased from 636.53 Cr in Mar'21 to 801.49 Cr in Mar'25, reflecting a consistent upward trend. Total operating income followed a similar trajectory, rising from 645.77 Cr in Mar'20 to 801.49 Cr in Mar'25. The company faced rising raw material costs, which increased from 98.92 Cr in Mar'21 to 195.34 Cr in Mar'25, while the purchase of finished goods also grew from 148.77 Cr to 186.95 Cr in the same period. Operating profit (PBDIT) showed fluctuations, peaking at 106.07 Cr in Mar'25 after a dip in Mar'22. Profit before tax rose significantly from 24.84 Cr in Mar'22 to 108.33 Cr in Mar'25, leading to a profit after tax of 81.66 Cr in Mar'25, up from 18.51 Cr in Mar'22. The company's total assets increased from 427.04 Cr in Mar'20 to 1,275.24 Cr in Mar'25, while total liabilities also rose, reflecting a growth in both equity capital and reserves. Cash flow from operating activities has been negative in recent years, indicating challenges in cash generation, although cash flow from investing activities remained positive. Overall, TTK Healthcare has demonstrated growth in sales and profitability, despite facing challenges with costs and cash flow management.

Is TTK Healthcare technically bullish or bearish?

As of December 3, 2025, the technical trend has shifted to a moderate bearish stance, driven by bearish MACD readings, Bollinger Bands, and daily moving averages, despite mixed signals from the RSI and KST, with the stock underperforming against the Sensex.

As of 3 December 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this include the bearish MACD readings on both the weekly and monthly time frames, bearish Bollinger Bands, and a bearish daily moving average. The RSI shows no signal on the weekly but is bullish on the monthly, indicating mixed signals. The KST is mildly bullish weekly but bearish monthly, while the OBV is mildly bearish weekly and mildly bullish monthly, adding to the overall bearish sentiment. The stock has underperformed significantly against the Sensex over multiple time frames, further supporting the bearish outlook.

Are TTK Healthcare Ltd. latest results good or bad?

TTK Healthcare Ltd.'s latest Q3 FY26 results are largely negative, showing a modest revenue increase of 2.81% but a significant net profit decline of 48.37%. The company's heavy reliance on non-operating income raises concerns about the sustainability of its earnings.

TTK Healthcare Ltd.'s latest results for Q3 FY26 present a mixed picture, but overall, they lean towards the negative side. While the company reported a modest revenue increase of 2.81% quarter-on-quarter and 2.23% year-on-year, its net profit saw a significant decline of 48.37% compared to the previous quarter and 37.06% year-on-year. This sharp drop in net profit, which fell to ₹10.53 crores, is particularly concerning given the stable revenue figures.<BR><BR>Moreover, the company's operating margins have also compressed, with the PAT margin declining from 10.02% in Q2 FY26 to just 5.03% in Q3 FY26. This indicates that despite maintaining revenue levels, TTK Healthcare is struggling with operational inefficiencies and rising costs.<BR><BR>A critical issue highlighted in the results is the company's heavy reliance on non-operating income, which constituted over 80% of its profit before tax. This dependency raises questions about the sustainability of its earnings and the effectiveness of its core business operations.<BR><BR>Overall, while TTK Healthcare has managed to grow its revenue slightly, the significant decline in profitability and the structural concerns regarding its reliance on non-operating income suggest that the latest results are more bad than good. Investors should be cautious and consider these factors when evaluating the company's performance and future prospects.

Should I buy, sell or hold TTK Healthcare Ltd.?

Why is TTK Healthcare Ltd. falling/rising?

As of 17-Mar, TTK Healthcare Ltd. is seeing a stock price increase to Rs 841.00 after two days of decline, indicating a potential trend reversal. However, it has underperformed year-to-date and shows a bearish trend with decreased investor participation.

As of 17-Mar, TTK Healthcare Ltd. is experiencing a rise in its stock price, currently at Rs 841.00, which reflects an increase of Rs 12.1 or 1.46%. This upward movement comes after two consecutive days of decline, indicating a potential trend reversal. Despite opening the day with a loss of 2.14% and touching an intraday low of Rs 807.05, the stock has managed to outperform its sector by 1.18%. <BR><BR>However, it is important to note that the stock has been underperforming over longer periods, with a year-to-date decline of 18.79% compared to a 10.74% drop in the Sensex. Additionally, TTK Healthcare is trading below its moving averages across various time frames, which suggests a bearish trend overall. Investor participation has also decreased significantly, with delivery volume falling by 46.87% against the 5-day average. <BR><BR>In summary, while TTK Healthcare Ltd. is currently rising in price after a brief decline, the broader context shows ongoing challenges, including lower investor participation and underperformance relative to benchmarks over the past year.

Why is TTK Healthcare Ltd. falling/rising?

As of 18-Mar, TTK Healthcare Ltd. is seeing a stock price increase to 834.00, up 1.86% after a trend reversal. However, it has a year-to-date decline of 19.47% and is facing long-term bearish trends and decreasing investor participation.

As of 18-Mar, TTK Healthcare Ltd. is experiencing a rise in its stock price, currently at 834.00, which reflects an increase of 15.25 or 1.86%. This upward movement comes after a trend reversal, as the stock has gained after three consecutive days of decline. Additionally, it has outperformed its sector by 1.59% today. <BR><BR>Despite this positive movement, the stock has been underperforming in the longer term, with a year-to-date decline of 19.47% and a one-year drop of 25.14%. It is also trading lower than its moving averages across various time frames, indicating a generally bearish trend. Furthermore, investor participation is falling, as evidenced by a decrease in delivery volume by 4.47% compared to the five-day average.<BR><BR>Overall, while TTK Healthcare Ltd. is currently rising in price, it is important to note the broader context of its recent performance and the challenges it faces in terms of long-term trends and investor engagement.

Why is TTK Healthcare Ltd. falling/rising?

As of 19-Mar, TTK Healthcare Ltd. is facing a decline in its stock price, currently at Rs 822.50, with significant underperformance over the past year and high volatility. Despite a brief gain today, overall sentiment remains negative due to proximity to its 52-week low and concerns over the company's fundamentals.

As of 19-Mar, TTK Healthcare Ltd. is experiencing a decline in its stock price, currently at Rs 822.50, which reflects a change of -8.05 (-0.97%). The stock has underperformed significantly over various time periods, with a year-to-date decline of -20.58% and a one-year drop of -26.58%. This poor performance is compounded by the fact that the stock is trading lower than its moving averages across multiple time frames, indicating a bearish trend.<BR><BR>Today, the stock opened with a gain of 4.75% and reached an intraday high of Rs 870, but it has shown high volatility with an intraday volatility of 5.47%. Despite outperforming its sector by 1.18% today, the overall sentiment remains negative due to the stock's proximity to its 52-week low, being only 1.88% away from Rs 807.<BR><BR>Additionally, the company's fundamentals raise concerns. Although it has a low debt-to-equity ratio and a reasonable return on equity (ROE) of 6.5, the stock is trading at a premium compared to its peers. The company has shown poor long-term growth, with net sales growing at an annual rate of only 6.99% over the last five years. Furthermore, domestic mutual funds hold only a minimal stake of 0.01%, suggesting a lack of confidence in the stock's valuation.<BR><BR>Overall, the combination of poor historical performance, high volatility, and low investor participation contributes to the downward pressure on TTK Healthcare Ltd.'s stock price.

Why is TTK Healthcare Ltd. falling/rising?

As of 20-Mar, TTK Healthcare Ltd. is facing a stock price decline to Rs 815.00, down 0.91%, and has significantly underperformed the Sensex with a year-to-date drop of 21.31%. The stock is nearing its 52-week low and shows bearish trends, compounded by decreased investor interest.

As of 20-Mar, TTK Healthcare Ltd. is experiencing a decline in its stock price, currently at Rs 815.00, which reflects a decrease of Rs 7.5 or 0.91%. The stock has underperformed compared to the benchmark Sensex, with a 1-week performance of -3.13% against a negligible change in the Sensex. Over the past month, TTK Healthcare has dropped by 12.27%, significantly more than the 10.00% decline in the Sensex.<BR><BR>Year-to-date, the stock is down 21.31%, while the Sensex has only decreased by 12.54%. Over the past year, TTK Healthcare's stock has fallen by 27.62%, contrasting sharply with the Sensex, which has only seen a 2.38% decline. This trend indicates a consistent underperformance relative to the market.<BR><BR>Additionally, the stock is close to its 52-week low, being just 0.98% away from Rs 807. The stock has also been on a downward trajectory, having fallen for the last two consecutive days, resulting in a total decline of 1.87% during this period. It is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically signals a bearish trend.<BR><BR>Investor participation has also decreased, with delivery volume on March 19 dropping by 67.35% compared to the 5-day average, indicating reduced interest in the stock. While the stock remains liquid enough for trading, these factors collectively contribute to the ongoing decline in TTK Healthcare's stock price.

Why is TTK Healthcare Ltd. falling/rising?

As of 23-Mar, TTK Healthcare Ltd. is facing a decline in its stock price, currently at Rs. 799.75, with a year-to-date drop of -22.78% and a recent 52-week low of Rs. 795.95. The stock is underperforming the market, trading below its moving averages, and experiencing reduced investor participation, indicating ongoing struggles.

As of 23-Mar, TTK Healthcare Ltd. is experiencing a decline in its stock price, currently at Rs. 799.75, which reflects a change of -12.65 (-1.56%). The stock has been on a downward trend, having fallen for the last three consecutive days, accumulating a total decline of -3.71% during this period. Today, the stock hit a new 52-week low of Rs. 795.95, indicating significant downward pressure.<BR><BR>In terms of performance, TTK Healthcare has underperformed compared to the broader market, with a year-to-date decline of -22.78%, which is notably worse than the Sensex's decline of -14.70%. Over the past year, the stock has decreased by -33.16%, while the Sensex has only fallen by -5.47%. This stark contrast highlights the stock's ongoing struggles.<BR><BR>Additionally, the stock is trading below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, suggesting a bearish trend. The sector itself, Pharmaceuticals & Drugs, has also seen a decline of -3.62%, which may be contributing to the negative sentiment surrounding TTK Healthcare.<BR><BR>Investor participation appears to be waning, as evidenced by a significant drop in delivery volume, which fell by -27.81% compared to the 5-day average. This reduction in trading activity may indicate a lack of confidence among investors, further exacerbating the stock's decline. Overall, the combination of poor performance metrics, sector weakness, and declining investor interest are key factors contributing to the falling stock price of TTK Healthcare Ltd.

Why is TTK Healthcare Ltd. falling/rising?

As of 24-Mar, TTK Healthcare Ltd. is facing a decline in stock price, currently at Rs. 786.00, with a total drop of -5.36% over the last four days and a new 52-week low of Rs. 773.5. The stock has significantly underperformed the market, showing negative returns across various time frames and trading below all major moving averages, indicating a persistent bearish trend.

As of 24-Mar, TTK Healthcare Ltd. is experiencing a decline in its stock price, currently at Rs. 786.00, which reflects a change of -13.75 (-1.72%). The stock has been underperforming significantly, with a consecutive fall over the last four days, resulting in a total decline of -5.36% during this period. Additionally, the stock hit a new 52-week low of Rs. 773.5 today, indicating a downward trend.<BR><BR>In terms of performance relative to the market, TTK Healthcare has shown negative returns across various time frames, including a -14.29% drop over the past month and a substantial -36.10% decline over the past year, compared to a much smaller -5.02% drop in the Sensex over the same period. This underperformance is further highlighted by the fact that the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a persistent bearish trend.<BR><BR>Despite a rise in investor participation, with delivery volume increasing by 44.36% against the 5-day average, the overall sentiment remains negative as the stock has underperformed its sector by -2.84% today. The liquidity of the stock is adequate for trading, but the prevailing downward momentum and recent price actions indicate that TTK Healthcare Ltd. is currently in a falling phase.

Why is TTK Healthcare Ltd. falling/rising?

As of 25-Mar, TTK Healthcare Ltd. has seen its stock price rise to Rs. 791.00 after a trend reversal, despite a year-to-date decline of -23.62% and a one-year return of -35.50%. While there are short-term gains, the long-term outlook remains uncertain due to weak growth prospects.

As of 25-Mar, TTK Healthcare Ltd. is experiencing a rise in its stock price, currently at Rs. 791.00, which reflects a change of 9.0 (1.15%) upward. This increase comes after a trend reversal where the stock gained after four consecutive days of decline. Despite opening the day with a loss of -2.17% and hitting a new 52-week low of Rs. 765, the stock managed to touch an intraday high of Rs. 816.05, indicating some recovery during the trading session.<BR><BR>However, it is important to note that the stock has been underperforming in the longer term, with a year-to-date decline of -23.62% and a one-year return of -35.50%. The stock is trading below its moving averages across multiple time frames, which suggests a bearish trend overall. Additionally, while the stock has seen a rise in investor participation, with delivery volume increasing by 92.45% against the five-day average, the overall performance has been below par compared to the sector.<BR><BR>The company has a low Debt to Equity ratio and an attractive valuation, but its long-term growth prospects appear weak, with net sales growing at an annual rate of only 6.99% over the last five years. This mixed performance, combined with the recent price movements, suggests that while there may be short-term gains, the long-term outlook remains uncertain.

Which are the latest news on TTK Healthcare?